Expired Canadian patentCanada
Use of botulinum toxin for the treatment of fine wrinkles and pore size
CA 2496005 C · Owner: Aquila, Rosemary · Inventors: Sanders, Ira; Aquila, Rosemary
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods of using clostridial toxins and other biological agents to control holocrine gland dysfunction in humans is provided. In preferred embodiments the methods provide beneficial effects in humans.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 18, 2003 and granted July 23, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 18, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 18, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 18, 2003
GrantedJuly 23, 2013
Term endedAugust 18, 2023
Patent numberCA 2496005 C
Classification (IPC)A61P43/00
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.